KIR3DL2
KIR3DL2 (killer cell immunoglobulin-like receptor 3DL2, also known as CD158K, cl-5, NKAT4, NKAT4A and NKAT4B) is a cell-surface receptor for MHC class I molecules on natural killer cells and T cells. It negatively regulates their effector functions. Browse Assay Genie's current range of KIR3DL2 research reagents below, or read on for the biology behind the target.
KIR3DL2 is a receptor on natural killer (NK) cells and T cells for MHC class I molecules. When it binds peptide-free HLA-F open conformer, it negatively regulates NK and T cell effector functions. It also acts as a receptor for HLA-F on astrocytes, and through this interaction it may protect motor neurons from astrocyte-induced toxicity.
The KIR3DL2 protein belongs to the immunoglobulin superfamily and is a transmembrane glycoprotein found at the cell membrane. Its name follows the standard KIR nomenclature: the number of extracellular immunoglobulin domains (3D) and a long (L) cytoplasmic domain. KIR proteins with a long cytoplasmic domain transduce inhibitory signals after ligand binding through an immune tyrosine-based inhibitory motif (ITIM). Short-tail KIR proteins lack the ITIM and instead associate with the TYRO protein tyrosine kinase binding protein to signal activation. The ligands for several KIR proteins are subsets of HLA class I molecules, so the family is thought to play an important role in regulating the immune response.
The KIR3DL2 gene sits in the KIR cluster within the leukocyte receptor complex on chromosome 19q13.4. KIR genes are polymorphic and highly homologous, and gene content varies between haplotypes. KIR3DL2 is one of the "framework" loci present on all haplotypes, together with KIR3DL3, KIR3DP1 and KIR3DL4. Alternatively spliced transcript variants encoding multiple isoforms have been observed. HGNC lists it in the CD molecules group as CD158K, and a previous name was killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2.
KIR3DL2 is an inhibitory receptor on NK cells that negatively regulates effector function after binding MHC class I ligands.
The receptor is expressed on subsets of T cells, where HLA-F binding negatively regulates T cell effector functions.
KIR3DL2 recognises peptide-free HLA-F open conformer, making it a useful receptor for studying this non-classical MHC interaction.
As an HLA-F receptor on astrocytes, KIR3DL2 may help protect motor neurons from astrocyte-induced toxicity.
KIR3DL2 is a receptor for MHC class I molecules on NK cells and T cells. On binding peptide-free HLA-F open conformer, it negatively regulates their effector functions. It is also an HLA-F receptor on astrocytes, where it may protect motor neurons from astrocyte-induced toxicity.
KIR3DL2 is also called CD158K, cl-5, NKAT4, NKAT4A and NKAT4B. Its full HGNC name is killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2. Alternatively spliced transcript variants encoding multiple isoforms have been observed for the gene.
Yes. KIR gene content varies among haplotypes, but KIR3DL2 is a framework gene found in all of them, alongside KIR3DL3, KIR3DP1 and KIR3DL4. The KIR genes are polymorphic, highly homologous and clustered in the leukocyte receptor complex on chromosome 19q13.4.
Other killer cell immunoglobulin-like receptors that share the KIR cluster and regulate NK and T cell responses to MHC class I.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P43630; product specifications from Assay Genie datasheets.